AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
EZETIMIBE 10.000 Mg ; SIMVASTATIN 40.000 Mg ;
15 registrations across 1 African market— 15 active
Markets with EZETIMIBE 10.000 Mg ; SIMVASTATIN 40.000 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Vastatinal 40/10 mg Tablets | 🇪🇬Egypt | universal pharmaceutical industries (unipharma) | active | — |
| VETOSIMVAMEB 10/40 mg Tablets | 🇪🇬Egypt | vetopharm nerhado international for pharmaceuticals and chemicals | active | — |
| JESTAMIVAM 10/40 mg Tablets | 🇪🇬Egypt | Egyptian Group for Pharmaceutical Industries - EGPI | active | — |
| SIMEZET Film Coated Tablets | 🇪🇬Egypt | organo for pharmaceutical and chemical industries (organo pharma) | active | — |
| Givarorock 10/40 mg Tablets | 🇪🇬Egypt | Chemedica | active | — |
| ALTOMANIRA Tablets | 🇪🇬Egypt | Bio Med For Pharmaceutical Industries (BIOMED) | active | — |
| SIMVASTIMIBE 10/40mg Tablets | 🇪🇬Egypt | Eva pharma for Pharmaceuticals and Medical Appliances - Eva Pharma | active | — |
| Simvastacare 10/40 mg Tablets | 🇪🇬Egypt | PHARMACARE EGYPT FOR TRADING AGENCY | active | — |
| Vastatinal 40/10 mg Tablets | 🇪🇬Egypt | universal pharmaceutical industries (unipharma) | active | — |
| Givarorock 10/40 mg Tablets | 🇪🇬Egypt | Chemedica | active | — |
| JESTAMIVAM 10/40 mg Tablets | 🇪🇬Egypt | Egyptian Group for Pharmaceutical Industries - EGPI | active | — |
| VETOSIMVAMEB 10/40 mg Tablets | 🇪🇬Egypt | vetopharm nerhado international for pharmaceuticals and chemicals | active | — |
| SIMEZET Film Coated Tablets | 🇪🇬Egypt | organo for pharmaceutical and chemical industries (organo pharma) | active | — |
| SIMVASTIMIBE 10/40mg Tablets | 🇪🇬Egypt | Eva pharma for Pharmaceuticals and Medical Appliances - Eva Pharma | active | — |
| Simvastacare 10/40 mg Tablets | 🇪🇬Egypt | PHARMACARE EGYPT FOR TRADING AGENCY | active | — |
EZETIMIBE 10.000 Mg ; SIMVASTATIN 40.000 Mg ; in Africa — Regulatory Overview
EZETIMIBE 10.000 Mg ; SIMVASTATIN 40.000 Mg ; is registered across 1 African markets with 15 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 15 registrations, 15 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.